Single Versus Double Perclose Devices for TF-TAVR Access Closure: A Noninferiority Randomized Controlled Trial.

Jubo Jiang1, Lihan Wang1, Po Hu1

  • 1Department of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China; Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou, China.

JACC. Asia
|March 26, 2026
PubMed
Summary

This randomized trial compares single versus double Perclose ProGlide devices for transfemoral transcatheter aortic valve replacement (TF-TAVR) vascular closure. It aims to determine the safest and most effective approach for large-bore access site management.

Related Concept Videos